Related Experiment Video
Updated: Nov 12, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.5K
Unexpected long-term survival in an adult patient with metastatic prostate cancer
P Antonov1,2, G Raycheva1,3, V Popov1,4
1Medical University, Plovdiv, Bulgaria.
Urology Case Reports
|March 22, 2021
Abstract:
According to statistics, the 5-year overall survival in metastatic prostate cancer is about 21 months. We present a case of a patient with castration-resistant prostate cancer with proven bone lesions 2 years after the onset of the disease and the current survival of over 9 years.

